Key facts
- Molecular Insight’s last known valuation is $200K (Sep 2025).
- It has raised $190K; the latest was Accelerator/Incubator in Oct 2025.
- Notable investors include Kanagawa Startup Acceleration, Kawasaki-NEDO Innovation Center, TECH HUB YOKOHAMA.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Molecular Insight
- ·The full record, as it builds
Funding rounds
No funding rounds for Molecular Insight are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Molecular Insight
Developer of a next-generation coherent Raman platform designed to make fast, complex liquid-phase chemistry visible in real time. The company offers a reagent-free, low-waste system that captures time-resolved molecular fingerprints directly from process streams, enabling biopharma, advanced materials, and energy manufacturers to accelerate formulation cycles, reduce failures, and improve production yields.
- Sector
- Business Products and Services (B2B)
- HQ
- Yokohama, Japan
- Founded
- 2024
- Employees
- 4
- Website
- molinsight.com/
- Ownership
- Privately Held (backing)
Molecular Insight doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Molecular Insight shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Molecular Insight in its N-PORT filings yet. We sweep new filings monthly.